News

In a LinkedIn post, the company’s Cardiovascular unit wrote that the Centers for Medicare and Medicaid Services (CMS) ...
St. Rita’s Medical Center now offers non-surgical treatment for tricuspid regurgitation or leaky heart valve, a condition in ...
The agency’s decision supports broader access to a minimally invasive treatment for patients with severe tricuspid ...
The overall evidence for the procedure is “insufficient” at present, but good enough to allow coverage, the agency says.
Holston Valley Medical Center has become the first hospital in Tennessee to successfully perform the EVOQUE tricuspid valve replacement procedure, a groundbreaking, minimally invasive therapy for pati ...
Round Rock is the first hospital in Central Texas to offer a new, minimally invasive cardiac procedure. The big picture In June, the medica ...
Among patients with atrial functional mitral regurgitation, severe tricuspid regurgitation is common and associated with worse outcomes.
The timing of the FDA approval was pivotal for Glenridge retiree Bob Fernander, who had been suffering from tricuspid regurgitation and shortness of breath for the past several years.
This freely accessible eBook is a comprehensive procedural guide to T-TEER, a groundbreaking minimally invasive therapy for tricuspid regurgitation (TR).
Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the need to understand its prognostic factors.
Tricuspid regurgitation is a life-threatening condition that affects an estimated 1.6 million Americans, according to the Journal of the American College of Cardiology.
Mild tricuspid regurgitation usually doesn't require treatment. Learn more about how what it is, possible treatment options, and outlook.